 | • レポートコード：D005-03428 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がん支持療法医学の世界市場を広く調査・分析し、今後の市場展望をまとめております。がん支持療法医学の種類別市場規模（制吐剤、エリスロポエチン刺激剤、顆粒球刺激剤、鎮痛剤、その他）、用途別市場規模（化学療法による貧血、CINV、骨転移、がん性疼痛、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Amgen、Kyowa Hakko Kirin、Merck、Helsinn Healthcare、Heron Therapeutics、Johnson &Johnson、TESARO、GlaxoSmithKline、F. Hoffmann-La Roche、Novartis、Teva Pharmaceutical Industries ・地域別グローバル市場分析 2015年-2020年 ・がん支持療法医学の北米市場（アメリカ、カナダ、メキシコ） ・がん支持療法医学のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がん支持療法医学のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がん支持療法医学の南米市場（ブラジル、アルゼンチン） ・がん支持療法医学の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：制吐剤、エリスロポエチン刺激剤、顆粒球刺激剤、鎮痛剤、その他 ・用途別分析：化学療法による貧血、CINV、骨転移、がん性疼痛、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Cancer Supportive Care Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cancer Supportive Care Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cancer Supportive Care Medicine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Supportive Care Medicine market has been segmented into
Antiemetic Drugs
Erythropoietin-Stimulating Agents
Granulocyte-Stimulating Agents
Analgesics
Others
By Application, Cancer Supportive Care Medicine has been segmented into:
Chemotherapy-Induced Anemia
CINV
Bone Metastasis
Cancer Pain
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Supportive Care Medicine market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Supportive Care Medicine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Supportive Care Medicine market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Supportive Care Medicine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Supportive Care Medicine Market Share Analysis
Cancer Supportive Care Medicine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Supportive Care Medicine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Supportive Care Medicine sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Supportive Care Medicine are:
Amgen
Kyowa Hakko Kirin
Merck
Helsinn Healthcare
Heron Therapeutics
Johnson &Johnson
TESARO
GlaxoSmithKline
F. Hoffmann-La Roche
Novartis
Teva Pharmaceutical Industries
Among other players domestic and global, Cancer Supportive Care Medicine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Supportive Care Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Supportive Care Medicine, with price, sales, revenue and global market share of Cancer Supportive Care Medicine in 2018 and 2019.
Chapter 3, the Cancer Supportive Care Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Supportive Care Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Cancer Supportive Care Medicine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Cancer Supportive Care Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Cancer Supportive Care Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Supportive Care Medicine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Antiemetic Drugs
1.2.3 Erythropoietin-Stimulating Agents
1.2.4 Granulocyte-Stimulating Agents
1.2.5 Analgesics
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Supportive Care Medicine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Chemotherapy-Induced Anemia
1.3.3 CINV
1.3.4 Bone Metastasis
1.3.5 Cancer Pain
1.3.6 Other
1.4 Overview of Global Cancer Supportive Care Medicine Market
1.4.1 Global Cancer Supportive Care Medicine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kyowa Hakko Kirin
2.2.1 Kyowa Hakko Kirin Details
2.2.2 Kyowa Hakko Kirin Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kyowa Hakko Kirin SWOT Analysis
2.2.4 Kyowa Hakko Kirin Product and Services
2.2.5 Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Helsinn Healthcare
2.4.1 Helsinn Healthcare Details
2.4.2 Helsinn Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Helsinn Healthcare SWOT Analysis
2.4.4 Helsinn Healthcare Product and Services
2.4.5 Helsinn Healthcare Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Heron Therapeutics
2.5.1 Heron Therapeutics Details
2.5.2 Heron Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Heron Therapeutics SWOT Analysis
2.5.4 Heron Therapeutics Product and Services
2.5.5 Heron Therapeutics Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson &Johnson
2.6.1 Johnson &Johnson Details
2.6.2 Johnson &Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson &Johnson SWOT Analysis
2.6.4 Johnson &Johnson Product and Services
2.6.5 Johnson &Johnson Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 TESARO
2.7.1 TESARO Details
2.7.2 TESARO Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 TESARO SWOT Analysis
2.7.4 TESARO Product and Services
2.7.5 TESARO Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline SWOT Analysis
2.8.4 GlaxoSmithKline Product and Services
2.8.5 GlaxoSmithKline Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 F. Hoffmann-La Roche
2.9.1 F. Hoffmann-La Roche Details
2.9.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 F. Hoffmann-La Roche SWOT Analysis
2.9.4 F. Hoffmann-La Roche Product and Services
2.9.5 F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novartis SWOT Analysis
2.10.4 Novartis Product and Services
2.10.5 Novartis Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Teva Pharmaceutical Industries
2.11.1 Teva Pharmaceutical Industries Details
2.11.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Teva Pharmaceutical Industries SWOT Analysis
2.11.4 Teva Pharmaceutical Industries Product and Services
2.11.5 Teva Pharmaceutical Industries Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cancer Supportive Care Medicine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Cancer Supportive Care Medicine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Supportive Care Medicine Manufacturer Market Share in 2019
3.3.2 Top 6 Cancer Supportive Care Medicine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cancer Supportive Care Medicine Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Supportive Care Medicine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Cancer Supportive Care Medicine Revenue and Market Share by Regions (2015-2020)
4.2 North America Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
4.3 Europe Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
4.5 South America Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Cancer Supportive Care Medicine Sales, Revenue and Market Share by Country
5.1.1 North America Cancer Supportive Care Medicine Sales and Market Share by Country (2015-2020)
5.1.2 North America Cancer Supportive Care Medicine Revenue and Market Share by Country (2015-2020)
5.2 United States Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
5.3 Canada Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
5.4 Mexico Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Cancer Supportive Care Medicine Sales, Revenue and Market Share by Country
6.1.1 Europe Cancer Supportive Care Medicine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Cancer Supportive Care Medicine Revenue and Market Share by Country (2015-2020)
6.2 Germany Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
6.3 UK Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
6.4 France Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
6.5 Russia Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
6.6 Italy Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cancer Supportive Care Medicine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cancer Supportive Care Medicine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Cancer Supportive Care Medicine Revenue and Market Share by Regions (2015-2020)
7.2 China Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
7.3 Japan Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
7.4 Korea Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
7.5 India Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
7.7 Australia Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Cancer Supportive Care Medicine Sales, Revenue and Market Share by Country
8.1.1 South America Cancer Supportive Care Medicine Sales and Market Share by Country (2015-2020)
8.1.2 South America Cancer Supportive Care Medicine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
8.3 Argentina Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cancer Supportive Care Medicine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cancer Supportive Care Medicine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Cancer Supportive Care Medicine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
9.3 Turkey Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
9.4 Egypt Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
9.5 South Africa Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Cancer Supportive Care Medicine Sales and Market Share by Type (2015-2020)
10.2 Global Cancer Supportive Care Medicine Revenue and Market Share by Type (2015-2020)
10.3 Global Cancer Supportive Care Medicine Price by Type (2015-2020)
11 Global Cancer Supportive Care Medicine Market Segment by Application
11.1 Global Cancer Supportive Care Medicine Sales Market Share by Application (2015-2020)
11.2 Global Cancer Supportive Care Medicine Revenue Market Share by Application (2015-2020)
11.3 Global Cancer Supportive Care Medicine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Cancer Supportive Care Medicine Sales, Revenue and Growth Rate (2021-2025)
12.2 Cancer Supportive Care Medicine Market Forecast by Regions (2021-2025)
12.2.1 North America Cancer Supportive Care Medicine Market Forecast (2021-2025)
12.2.2 Europe Cancer Supportive Care Medicine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Cancer Supportive Care Medicine Market Forecast (2021-2025)
12.2.4 South America Cancer Supportive Care Medicine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Cancer Supportive Care Medicine Market Forecast (2021-2025)
12.3 Cancer Supportive Care Medicine Market Forecast by Type (2021-2025)
12.3.1 Global Cancer Supportive Care Medicine Sales Forecast by Type (2021-2025)
12.3.2 Global Cancer Supportive Care Medicine Market Share Forecast by Type (2021-2025)
12.4 Cancer Supportive Care Medicine Market Forecast by Application (2021-2025)
12.4.1 Global Cancer Supportive Care Medicine Sales Forecast by Application (2021-2025)
12.4.2 Global Cancer Supportive Care Medicine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Cancer Supportive Care Medicine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Supportive Care Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Supportive Care Medicine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Cancer Supportive Care Medicine Major Business
Table 9. Amgen Cancer Supportive Care Medicine Total Revenue (USD Million) (2017-2018)
Table 10. Amgen SWOT Analysis
Table 11. Amgen Cancer Supportive Care Medicine Product and Services
Table 12. Amgen Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 14. Kyowa Hakko Kirin Cancer Supportive Care Medicine Major Business
Table 15. Kyowa Hakko Kirin Cancer Supportive Care Medicine Total Revenue (USD Million) (2017-2018)
Table 16. Kyowa Hakko Kirin SWOT Analysis
Table 17. Kyowa Hakko Kirin Cancer Supportive Care Medicine Product and Services
Table 18. Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Cancer Supportive Care Medicine Major Business
Table 21. Merck Cancer Supportive Care Medicine Total Revenue (USD Million) (2017-2018)
Table 22. Merck SWOT Analysis
Table 23. Merck Cancer Supportive Care Medicine Product and Services
Table 24. Merck Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Helsinn Healthcare Basic Information, Manufacturing Base and Competitors
Table 26. Helsinn Healthcare Cancer Supportive Care Medicine Major Business
Table 27. Helsinn Healthcare Cancer Supportive Care Medicine Total Revenue (USD Million) (2017-2018)
Table 28. Helsinn Healthcare SWOT Analysis
Table 29. Helsinn Healthcare Cancer Supportive Care Medicine Product and Services
Table 30. Helsinn Healthcare Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table 32. Heron Therapeutics Cancer Supportive Care Medicine Major Business
Table 33. Heron Therapeutics Cancer Supportive Care Medicine Total Revenue (USD Million) (2017-2018)
Table 34. Heron Therapeutics SWOT Analysis
Table 35. Heron Therapeutics Cancer Supportive Care Medicine Product and Services
Table 36. Heron Therapeutics Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Johnson &Johnson Basic Information, Manufacturing Base and Competitors
Table 38. Johnson &Johnson Cancer Supportive Care Medicine Major Business
Table 39. Johnson &Johnson Cancer Supportive Care Medicine Total Revenue (USD Million) (2017-2018)
Table 40. Johnson &Johnson SWOT Analysis
Table 41. Johnson &Johnson Cancer Supportive Care Medicine Product and Services
Table 42. Johnson &Johnson Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. TESARO Basic Information, Manufacturing Base and Competitors
Table 44. TESARO Cancer Supportive Care Medicine Major Business
Table 45. TESARO Cancer Supportive Care Medicine Total Revenue (USD Million) (2017-2018)
Table 46. TESARO SWOT Analysis
Table 47. TESARO Cancer Supportive Care Medicine Product and Services
Table 48. TESARO Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 50. GlaxoSmithKline Cancer Supportive Care Medicine Major Business
Table 51. GlaxoSmithKline Cancer Supportive Care Medicine Total Revenue (USD Million) (2017-2018)
Table 52. GlaxoSmithKline SWOT Analysis
Table 53. GlaxoSmithKline Cancer Supportive Care Medicine Product and Services
Table 54. GlaxoSmithKline Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 56. F. Hoffmann-La Roche Cancer Supportive Care Medicine Major Business
Table 57. F. Hoffmann-La Roche Cancer Supportive Care Medicine Total Revenue (USD Million) (2017-2018)
Table 58. F. Hoffmann-La Roche SWOT Analysis
Table 59. F. Hoffmann-La Roche Cancer Supportive Care Medicine Product and Services
Table 60. F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Cancer Supportive Care Medicine Major Business
Table 63. Novartis Cancer Supportive Care Medicine Total Revenue (USD Million) (2017-2018)
Table 64. Novartis SWOT Analysis
Table 65. Novartis Cancer Supportive Care Medicine Product and Services
Table 66. Novartis Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceutical Industries Cancer Supportive Care Medicine Major Business
Table 69. Teva Pharmaceutical Industries Cancer Supportive Care Medicine Total Revenue (USD Million) (2017-2018)
Table 70. Teva Pharmaceutical Industries SWOT Analysis
Table 71. Teva Pharmaceutical Industries Cancer Supportive Care Medicine Product and Services
Table 72. Teva Pharmaceutical Industries Cancer Supportive Care Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Cancer Supportive Care Medicine Sales by Manufacturer (2018-2019) (K MT)
Table 74. Global Cancer Supportive Care Medicine Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Cancer Supportive Care Medicine Sales by Regions (2015-2020) (K MT)
Table 76. Global Cancer Supportive Care Medicine Sales Market Share by Regions (2015-2020)
Table 77. Global Cancer Supportive Care Medicine Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Cancer Supportive Care Medicine Sales by Countries (2015-2020) (K MT)
Table 79. North America Cancer Supportive Care Medicine Sales Market Share by Countries (2015-2020)
Table 80. North America Cancer Supportive Care Medicine Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Cancer Supportive Care Medicine Revenue Market Share by Countries (2015-2020)
Table 82. Europe Cancer Supportive Care Medicine Sales by Countries (2015-2020) (K MT)
Table 83. Europe Cancer Supportive Care Medicine Sales Market Share by Countries (2015-2020)
Table 84. Europe Cancer Supportive Care Medicine Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Cancer Supportive Care Medicine Sales by Regions (2015-2020) (K MT)
Table 86. Asia-Pacific Cancer Supportive Care Medicine Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Cancer Supportive Care Medicine Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Cancer Supportive Care Medicine Sales by Countries (2015-2020) (K MT)
Table 89. South America Cancer Supportive Care Medicine Sales Market Share by Countries (2015-2020)
Table 90. South America Cancer Supportive Care Medicine Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Cancer Supportive Care Medicine Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Cancer Supportive Care Medicine Sales by Countries (2015-2020) (K MT)
Table 93. Middle East & Africa Cancer Supportive Care Medicine Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Cancer Supportive Care Medicine Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Cancer Supportive Care Medicine Revenue Market Share by Countries (2015-2020)
Table 96. Global Cancer Supportive Care Medicine Sales by Type (2015-2020) (K MT)
Table 97. Global Cancer Supportive Care Medicine Sales Share by Type (2015-2020)
Table 98. Global Cancer Supportive Care Medicine Revenue by Type (2015-2020) (USD Million)
Table 99. Global Cancer Supportive Care Medicine Revenue Share by Type (2015-2020)
Table 100. Global Cancer Supportive Care Medicine Sales by Application (2015-2020) (K MT)
Table 101. Global Cancer Supportive Care Medicine Sales Share by Application (2015-2020)
Table 102. Global Cancer Supportive Care Medicine Sales Forecast by Regions (2021-2025) (K MT)
Table 103. Global Cancer Supportive Care Medicine Market Share Forecast by Regions (2021-2025)
Table 104. Global Cancer Supportive Care Medicine Sales Forecast by Type (2021-2025) (K MT)
Table 105. Global Cancer Supportive Care Medicine Market Share Forecast by Type (2021-2025)
Table 106. Global Cancer Supportive Care Medicine Sales Forecast by Application (2021-2025)
Table 107. Global Cancer Supportive Care Medicine Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Cancer Supportive Care Medicine Picture
Figure 2. Global Sales Market Share of Cancer Supportive Care Medicine by Type in 2019
Figure 3. Antiemetic Drugs Picture
Figure 4. Erythropoietin-Stimulating Agents Picture
Figure 5. Granulocyte-Stimulating Agents Picture
Figure 6. Analgesics Picture
Figure 7. Others Picture
Figure 8. Cancer Supportive Care Medicine Sales Market Share by Application in 2018
Figure 9. Chemotherapy-Induced Anemia Picture
Figure 10. CINV Picture
Figure 11. Bone Metastasis Picture
Figure 12. Cancer Pain Picture
Figure 13. Other Picture
Figure 14. Global Cancer Supportive Care Medicine Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Cancer Supportive Care Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Cancer Supportive Care Medicine Sales Market Share by Manufacturer in 2019
Figure 35. Global Cancer Supportive Care Medicine Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Cancer Supportive Care Medicine Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Cancer Supportive Care Medicine Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 40. Global Cancer Supportive Care Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Cancer Supportive Care Medicine Revenue Market Share by Regions (2015-2020)
Figure 42. Global Cancer Supportive Care Medicine Revenue Market Share by Regions in 2018
Figure 43. North America Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
Figure 44. Europe Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
Figure 46. South America Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020)
Figure 48. North America Cancer Supportive Care Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Cancer Supportive Care Medicine Sales Market Share by Countries (2015-2020)
Figure 50. North America Cancer Supportive Care Medicine Sales Market Share by Countries in 2018
Figure 51. North America Cancer Supportive Care Medicine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Cancer Supportive Care Medicine Revenue Market Share by Countries in 2018
Figure 53. United States Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Canada Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Mexico Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 56. Europe Cancer Supportive Care Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Cancer Supportive Care Medicine Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Cancer Supportive Care Medicine Revenue Market Share by Countries in 2019
Figure 59. Germany Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 60. UK Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 61. France Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Russia Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Italy Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Asia-Pacific Cancer Supportive Care Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Cancer Supportive Care Medicine Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Cancer Supportive Care Medicine Revenue Market Share by Regions 2019
Figure 67. China Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Japan Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Korea Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 70. India Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Southeast Asia Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 72. South America Cancer Supportive Care Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Cancer Supportive Care Medicine Sales Market Share by Countries in 2019
Figure 74. South America Cancer Supportive Care Medicine Revenue Market Share by Countries in 2019
Figure 75. Brazil Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Argentina Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Middle East and Africa Cancer Supportive Care Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Cancer Supportive Care Medicine Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Cancer Supportive Care Medicine Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Cancer Supportive Care Medicine Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Egypt Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Turkey Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 84. South Africa Cancer Supportive Care Medicine Sales and Growth Rate (2015-2020) (K MT)
Figure 85. Global Cancer Supportive Care Medicine Sales and Growth Rate (2021-2025) (K MT)
Figure 86. Global Cancer Supportive Care Medicine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Cancer Supportive Care Medicine Market Forecast (2021-2025) (K MT)
Figure 88. Europe Sales Cancer Supportive Care Medicine Market Forecast (2021-2025) (K MT)
Figure 89. Asia-Pacific Sales Cancer Supportive Care Medicine Market Forecast (2021-2025) (K MT)
Figure 90. South America Sales Cancer Supportive Care Medicine Market Forecast (2021-2025) (K MT)
Figure 91. Middle East & Africa Sales Cancer Supportive Care Medicine Market Forecast (2021-2025) (K MT)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
子宮頸がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cervical Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 14770 million by 2025, from USD 13550 million in 2019. The Cervical Cancer …- 化学療法誘発悪心＆嘔吐（CINV）用薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2…
- 乳がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Breast Cancer Therapeutics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Breast Cance…
- CD抗原がん治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global CD Antigen Cancer Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The CD Antigen Cancer T…
- がん免疫調節剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cancer Immunomodulator market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Immunomodulator…